161 related articles for article (PubMed ID: 32372148)
41. Clinical usefulness of diagnostic criteria for transplant-associated thrombotic microangiopathy.
Sagou K; Fukushima N; Ukai S; Goto M; Ozeki K; Kohno A
Int J Hematol; 2020 Nov; 112(5):697-706. PubMed ID: 32748214
[TBL] [Abstract][Full Text] [Related]
42. Successful Treatment of Veno-occlusive Disease, Transplantation-Associated Thrombotic Microangiopathy, and Acute Graft-vs-Host Disease in a Patient with Relapsed Epstein-Barr Hemophagocytic Lymphohistiocytosis After Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report.
Zhang C; Tan X; Yao H; Liu Y; Gao L; Gao L; Kong PY; Zhang X
Transplant Proc; 2019 Nov; 51(9):3159-3162. PubMed ID: 31711585
[TBL] [Abstract][Full Text] [Related]
43. C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Elhadad S; Chadburn A; Magro C; Van Besien K; Roberson EDO; Atkinson JP; Terry H; Greenberg J; Reid W; Chapin J; Copertino D; Geramfard S; Rodriguez LB; Orfali N; Gerghis U; Shore T; Mayer S; Ahamed J; Laurence J
Bone Marrow Transplant; 2022 Sep; 57(9):1445-1447. PubMed ID: 35661836
[No Abstract] [Full Text] [Related]
44. Successful treatment of refractory acute GVHD complicated by severe intestinal transplant-associated thrombotic microangiopathy using recombinant thrombomodulin.
Inoue Y; Kosugi S; Miura I; Hatta Y; Takeuchi J
Thromb Res; 2011 Jun; 127(6):603-4. PubMed ID: 21262525
[No Abstract] [Full Text] [Related]
45. Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation.
Yamada-Fujiwara M; Miyamura K; Fujiwara T; Tohmiya Y; Endo K; Onishi Y; Ishizawa K; Kameoka J; Ito M; Harigae H
Tohoku J Exp Med; 2012 May; 227(1):31-7. PubMed ID: 22531159
[TBL] [Abstract][Full Text] [Related]
46. Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Jodele S; Fukuda T; Vinks A; Mizuno K; Laskin BL; Goebel J; Dixon BP; Teusink A; Pluthero FG; Lu L; Licht C; Davies SM
Biol Blood Marrow Transplant; 2014 Apr; 20(4):518-25. PubMed ID: 24370861
[TBL] [Abstract][Full Text] [Related]
47. Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Jodele S; Hirsch R; Laskin B; Davies S; Witte D; Chima R
Biol Blood Marrow Transplant; 2013 Feb; 19(2):202-7. PubMed ID: 22960385
[TBL] [Abstract][Full Text] [Related]
48. Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy.
Dandoy CE; Davies SM; Hirsch R; Chima RS; Paff Z; Cash M; Ryan TD; Lane A; El-Bietar J; Myers KC; Jodele S
Biol Blood Marrow Transplant; 2015 Jan; 21(1):113-8. PubMed ID: 25300868
[TBL] [Abstract][Full Text] [Related]
49. Disseminated cryptococcal infection in allogeneic stem cell transplant patients: a rare cause of acute kidney injury.
Oliver N; Luong T; Tchakarov A; Abdelrahim M; Mulanovich VE; Kontoyiannis DP; Jones R; Kebriaei P; Samuels J; Glass W; Abudayyeh A
Bone Marrow Transplant; 2016 Oct; 51(10):1301-1304. PubMed ID: 27159179
[TBL] [Abstract][Full Text] [Related]
50. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study.
Siami K; Kojouri K; Swisher KK; Selby GB; George JN; Laszik ZG
Transplantation; 2008 Jan; 85(1):22-8. PubMed ID: 18192907
[TBL] [Abstract][Full Text] [Related]
51. Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease.
Ishikawa Y; Nishio S; Sasaki H; Kudo R; Goto H; Ito M; Suzuki A; Fukazawa Y; Mochizuki T; Koike T
Clin Exp Nephrol; 2011 Feb; 15(1):179-83. PubMed ID: 21120571
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of Recombinant Human Soluble Thrombomodulin in Treating Disseminated Intravascular Coagulation Complicating Allogeneic Hematopoietic Stem Cell Transplantation.
Inoue Y; Matsunawa M; Sano F; Miura I
Acta Haematol; 2018; 140(2):121-127. PubMed ID: 30227394
[TBL] [Abstract][Full Text] [Related]
53. [Secondary thrombotic microangiopathies].
Coppo P;
Rev Med Interne; 2017 Nov; 38(11):731-736. PubMed ID: 28890263
[TBL] [Abstract][Full Text] [Related]
54. Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer.
George JN; Terrell DR; Vesely SK; Kremer Hovinga JA; Lämmle B
Presse Med; 2012 Mar; 41(3 Pt 2):e177-88. PubMed ID: 22244728
[TBL] [Abstract][Full Text] [Related]
55. Eculizumab and thrombotic microangiopathy after hematopoietic stem cell transplantation: A report on its efficacy and safety in two pediatric patients.
Genere L; Bacchetta J; Bertrand Y; Javouhey E; Cheikh N; Sellier-Leclerc AL
Arch Pediatr; 2018 Nov; 25(8):485-488. PubMed ID: 30340942
[TBL] [Abstract][Full Text] [Related]
56. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
[TBL] [Abstract][Full Text] [Related]
57. A case of chronic kidney disease with thrombotic microangiopathy in a hematopoietic stem cell transplant recipient.
Maeda K; Suzuki K; Mizutani M; Watanabe H; Suga N; Kitagawa W; Miura N; Nishikawa K; Uchida K; Imai H
Clin Exp Nephrol; 2010 Oct; 14(5):474-8. PubMed ID: 20473542
[TBL] [Abstract][Full Text] [Related]
58. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
Khosla J; Yeh AC; Spitzer TR; Dey BR
Bone Marrow Transplant; 2018 Feb; 53(2):129-137. PubMed ID: 28967899
[TBL] [Abstract][Full Text] [Related]
59. [Allogeneic hematopoietic stem cell transplantation associated thrombotic microangiopathy: 16 cases report and literature review].
Han W; Han Y; Chen J; Ma X; Chen F; Wu XJ; Qi JQ; Qiu HY; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):666-70. PubMed ID: 27587247
[TBL] [Abstract][Full Text] [Related]
60. Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation: A Comparison of Eculizumab Therapy and Conventional Therapy.
Bohl SR; Kuchenbauer F; von Harsdorf S; Kloevekorn N; Schönsteiner SS; Rouhi A; Schwarzwälder P; Döhner H; Bunjes D; Bommer M
Biol Blood Marrow Transplant; 2017 Dec; 23(12):2172-2177. PubMed ID: 28860002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
